General Dermatology

Take a deep dive into the 3 approvals for various dermatological conditions this month.

Researchers reported gender differences among individuals with skin conditions and compared sociodemographic, clinical and psychological variables.

Explore how BCs are supported through complex drug approvals and ensuring patients have access to prescribed medications.

Combining electrocoagulation with pharmacotherapy significantly reduced keloid scar volume by inhibiting collagen deposition, angiogenesis, and cell proliferation.

A recent study examined skin manifestations and SS from a dermatological perspective.

Researchers noted that many dermatologists face mild, non-life-threatening complications during procedures, yet must be prepared for emergencies.

A recent review investigated all known information between skin conditions and sleep disorders, finding a bidirectional influence between them.

Keep up with the latest headlines in dermatology from the past week, including racial disparities in hidradenitis suppurativa, Stanford Medicine's new Skin of Color program, and more.

In case you missed it, this week we had news about Oleogel-10's potential in dressing changes for pediatric patients with epidermolysis bullosa, data for repigmentation with ruxolitinib cream, a review of pediatric cutaneous Crohn disease, and more.

The study saw a reduction of 2 major UVA-induced mtDNA deletions associated with skin photoaging.

A recent case series reviewed the treatment patterns and effects of therapies on 89 pediatric patients with CCD.

TMB-001 0.05% demonstrates promising efficacy and safety in treating moderate to severe congenital ichthyosis, according to a poster presented at the SPD's annual meeting.

Preoperative pain and anticipated postoperative pain were found to predict postoperative pain in patients undergoing dermatologic surgery.

Explore dermatology's history and the journey through our publication's 45 years of covering an ever evolving specialty.

July 8th has been established as World Skin Health Day, with celebrations planned and anticipated on a global scale.

Keep up with the latest headlines in dermatology from the past week, including the appointment of the Canadian Dermatology Association's new president, a program aimed at supporting diverse, aspiring dermatologists, and more.

In case you missed it, this week we had news about the FDA's approval of biosimilar ustekinumab-ttwe, addressing acne scarring concerns, the intersection of permanent makeup and dermatology, and more.

Dermatology Times' Summer Editor in Chief, Shanna Miranti, MPAS, PA-C, shares how she has learned to be happy, stay humble, and be brilliant in her more than 22 years in dermatology.

Shahriari spoke about the importance of comprehensive care, collaborating with other specialists, and addressing psychosocial impact.

The first issue of Dermatology Times was published in 1979 to offer clinical insights into a growing health care specialty.

As many as 76.5% of participants could not name any psychodermatology resources, while only 58.8% were definitively interested in training on the topic.

Explore evidence-based clinical recommendations for fireworks burns, chlorine irritation, and more.

A recent review found success from a 3-component, simplified habit reversal therapy implemented by dermatologists for BFRBs.

Keep up with the latest headlines in dermatology from the past week, including application of AI in dermatology, exposure to forever chemicals through the skin, and more.

Dermatology Times is looking back on the top stories in dermatology from the month of June.

Dermatology Times is recapping our top expert interviews from the month of June.

Recent research has shed light on public interest of BPO utilizing relative search volume data.

Keep up with the latest headlines in dermatology from the past week, including a first-of-its-kind study linking psoriasis and OCD, DermTech's Chapter 11 bankruptcy filing, and more.

Botanix Pharmaceuticals announced the approval of its sofpironium topical gel, 12.45% for adults and children ages 9 and older.

LC-OCT non-invasively assessed non-structural changes from botulinum toxin and irreversible tissue changes from microwave thermolysis in hyperhidrosis.